ELETRIPTAN GPPL, ELTRIPAX, ELPAXTAN, ELYSS, ELETRIPTAN GENPAR, ELETRIPTAN GXP, ELETX (Generic Partners Pty Ltd)
Product name
ELETRIPTAN GPPL, ELTRIPAX, ELPAXTAN, ELYSS, ELETRIPTAN GENPAR, ELETRIPTAN GXP, ELETX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
186 working days (255)
Active ingredients
eletriptan
Registration type
New generic medicine
Indication
ELETRIPTAN GPPL, ELTRIPAX, ELPAXTAN, ELYSS, ELETRIPTAN GENPAR, ELETRIPTAN GXP, ELETX (film-coated tablets) are indicated for acute treatment of migraine headache with or without aura.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine